CRWV holders report large Rule 144/10b5-1 sales
CRWV-related holders reported multiple proposed sales of Common Stock under Rule 144 and pursuant to 10b5-1 plans.
Rhea-AI Filing Summary
CRWV-related holders reported multiple proposed sales of Common Stock under Rule 144 and pursuant to 10b5-1 plans.
The excerpt lists a series of executed or planned transactions dated between 04/02/2026 and 06/30/2026, showing individual sale lots (examples include 900,000 shares for $104,339,070.00 and 300,000 shares for $38,033,010.00) attributed to entities and trusts associated with the named reporting persons.
Positive
- None.
Negative
- None.
Insights
Multiple scheduled dispositions under Rule 144 and 10b5-1 plans are documented; timing and scale are issuer-associated holder activity.
The excerpt lists recurring sales by named holders and associated entities across many dates in April–June 2026, with large single-lot sizes such as 900,000 shares for $104,339,070.00. These entries are recorded as 10b5-1 Sales, indicating pre-arranged trading plans.
Cash-flow treatment is tied to the selling holders; the filing does not state proceeds to the issuer. Subsequent filings may state aggregated totals or changes in ownership percentages.
Key Figures
Key Terms
10b5-1 Sales regulatory
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the CRWV Form 144 filing show?
Who are the sellers in the CRWV filing?
Are the sales proceeds paid to the issuer (CRWV)?
What are examples of sale sizes in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.